Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Tru Niagen Immune is a multi-ingredient dietary supplement developed and marketed by ChromaDex Corp. under the Tru Niagen brand. It is specifically formulated to support year-round immune health and cellular energy. The product's primary active ingredient is **Niagen** (nicotinamide riboside chloride), a patented small molecule precursor to **nicotinamide adenine dinucleotide (NAD+)**. NAD+ is a vital coenzyme found in all living cells that plays a crucial role in energy metabolism and maintaining cellular health, but its levels can be depleted by physiological stressors, including immune challenges. The current formulation of Tru Niagen Immune includes 100mg of Niagen, plant-based Vitamin D3 (VegD3), fermentation-derived Vitamin C, zinc in two bioavailable forms, selenium, and copper. An earlier version of the product contained 150mg of Niagen and included Theracurmin (a highly absorbable curcumin). It is designed as a daily companion supplement to be taken alongside standard Tru Niagen NAD+ boosters for comprehensive cellular and immune support.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Tru Niagen Immune.